What you are also missing in facts re purchase is QIN has a processing facility Mt Romance (Purchased if memory serves at $13.2m with current EBITDA, today 3x)
Also, Santalis Pharma, another $25mil USD but now with Phase 3 trails, numerous Phase 2 and Aus patents. Anyone done the research on FDA approved pharma and IPO value. Well 89.4% of phamra on phase 3 get approval. DYOR but if I wanted to take the time I could list at least 10 past US IPO that listed above $500 mil USD
There is value in this coy. If it can stay liquid for 2 years.
GLAH x S
They also own
QIN Price at posting:
29.5¢ Sentiment: Hold Disclosure: Held
